List of IQVIA OCE Customers
Cambridge, CB4 0WG,
United Kingdom
Since 2010, our global team of researchers has been studying IQVIA OCE customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased IQVIA OCE for Customer Engagement from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using IQVIA OCE for Customer Engagement include: Roche, a Switzerland based Life Sciences organisation with 112774 employees and revenues of $80.28 billion, AstraZeneca, a United Kingdom based Life Sciences organisation with 94300 employees and revenues of $73.98 billion, Novo Nordisk, a Denmark based Life Sciences organisation with 78554 employees and revenues of $45.92 billion, Sagent Pharmaceuticals, a United States based Life Sciences organisation with 440 employees and revenues of $80.0 million, Theramex, a United Kingdom based Life Sciences organisation with 510 employees and revenues of $57.0 million and many others.
Contact us if you need a completed and verified list of companies using IQVIA OCE, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The IQVIA OCE customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | IQVIA | IQVIA OCE | Customer Engagement | 2019 | n/a |
In 2019 AstraZeneca implemented IQVIA OCE to advance its digital agenda and establish a Field of the Future for customer-facing teams. The deployment began with an initial rollout in the United States, explicitly targeting Oncology and specialized medicines to support complex account coverage and multi-disciplinary engagement models.
IQVIA OCE Orchestrated Customer Engagement platform was configured to provide a unified, continuously updated account view and orchestration capabilities for multiple field users who call on the same large accounts. Core functional capabilities implemented included customer engagement orchestration, shared interaction timelines, decision support driven by machine learning algorithms, and advanced analytics for customer insights and engagement planning.
The implementation is powered by IQVIA CORE and was positioned to unify and coordinate AstraZeneca sales, in-house marketing and medical functions, reducing operational and information silos across teams. The Customer Engagement solution enabled collaboration workflows that allow users in sales, medical and marketing roles to share consistent interaction records and align outreach strategies for complex accounts.
Governance and process changes focused on information sharing and role-based access to the shared account view, enabling coordinated engagement and improved decision making. Reported platform benefits included enhanced customer insights, improved decision making and optimized individual engagements, all delivered through the IQVIA OCE Customer Engagement framework.
|
 |
FORUM Pharmaceuticals | Life Sciences | 60 | $10M | United States | IQVIA | IQVIA OCE | Customer Engagement | 2015 | n/a |
In 2015, FORUM Pharmaceuticals implemented IQVIA OCE, IQVIA Orchestrated Customer Engagement, as its Customer Engagement solution on the company website. The deployment was site-centric and focused on web-based orchestration and digital engagement workflows sized to a small life sciences commercial organization. The implementation emphasized online content delivery, visitor interaction tracking, and audience segmentation capabilities that align with Orchestrated Customer Engagement functionality.
IQVIA Orchestrated Customer Engagement was embedded into the website to execute engagement logic, personalize on-site content, and capture interaction events for commercial and marketing follow up, with configuration and campaign management owned by the marketing and commercial teams. Operational coverage is limited to the corporate website and commercial functions, enabling campaign orchestration, sequenced engagement flows, and engagement reporting as core operational capabilities. Governance was structured around centralized campaign configuration and role-based access to the IQVIA OCE instance to control messaging and content changes.
|
 |
Novo Nordisk | Life Sciences | 78554 | $45.9B | Denmark | IQVIA | IQVIA OCE | Customer Engagement | 2018 | n/a |
In 2018, Novo Nordisk selected IQVIA OCE, IQVIA’s Orchestrated Customer Engagement platform, for deployment across Novo Nordisk International Operations. The selection targeted Customer Engagement to connect marketing, sales, medical science liaisons, account management and other customer facing functions, positioning IQVIA OCE to support commercial and medical engagement workflows within Novo Nordisk.
The implementation emphasizes orchestrated customer engagement workflows and decision support features, including predictive analytics and machine learning capabilities called out by IQVIA. Configuration work focused on aligning multichannel engagement orchestration and field force coordination to commercial and medical science liaison processes.
Architecturally IQVIA OCE is built on Salesforce.com, MuleSoft, Amazon Web Services, Heroku and Box, creating an integrated stack that combines CRM, API middleware and cloud infrastructure to enable data driven engagement and optimized performance. Integrations were designed to surface analytics and content to field teams and to centralize engagement records for account management and marketing functions.
Governance and rollout were planned at the international operations level with a global rollout excluding Canada and the U.S., and with Novo Nordisk planning to switch existing platforms to IQVIA OCE in 2019 and beyond. The stated operational goals were to streamline processes, further develop customer relationships and better anticipate and respond to market changes, impacting commercial, medical and account management workflows and requiring cross functional coordination for orchestration of customer engagement.
|
 |
|
Life Sciences | 112774 | $80.3B | Switzerland | IQVIA | IQVIA OCE | Customer Engagement | 2018 | n/a |
|
|
|
|
Life Sciences | 440 | $80M | United States | IQVIA | IQVIA OCE | Customer Engagement | 2015 | n/a |
|
|
|
|
Life Sciences | 510 | $57M | United Kingdom | IQVIA | IQVIA OCE | Customer Engagement | 2018 | n/a |
|
Buyer Intent: Companies Evaluating IQVIA OCE
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||